Impact Minerals Limited (ASX: IPT) has resumed exploration at its 100%-owned Broken Hill Project (NSW), citing stronger metal prices, new in-house copper concepts from the BHP Xplor program, and renewed third-party activity in the district (Figure 1). The Company has begun a progressive review of past work and presents context and results from Platinum Springs as the first step.

Critica Limited (ASX: CRI) has released two major updates that strengthen the technical and strategic credentials of the Jupiter Project, located in Western Australia. The Company has successfully produced its first high-grade Mixed Rare Earth Product (MREP) and, in parallel, delivered confirmation that gallium can be recovered as a valuable by-product within the same beneficiation-first flowsheet.

Terra Critical Minerals Limited (ASX: T92) has taken a decisive step into the North American critical minerals landscape with the acquisition of the True American Tungsten Project, located in central Nevada at the junction of the prolific Getchell and Battle Mountain Mineral Belts (Figure 1).

Great Dirt Resources Limited (ASX: GR8) continues to advance its 100%-owned Doherty and Basin Manganese Projects located within EL9527 near Barraba, northern New South Wales (Figure 1). Recent surface sampling across historic workings at the Basin (Copper Hill) and Neranghi areas has confirmed high-grade manganese oxide occurrences, with assays reaching up to 51.8% Mn, reinforcing the district’s potential to host significant manganese systems.

G11 Resources Limited (ASX: G11) has moved decisively in 2025 to expand its footprint across two of Australia’s most prospective mineral belts—Tasmania’s Mt Read Volcanics and the frontier structural corridors of north-western New South Wales (Figure 1). Through the acquisition of Pacific State Metals and further modelling work released later in the year, the Company has unlocked a pipeline of untested gold–copper targets with the scale and geological positioning required for

Caprice Resources Ltd (ASX: CRS) has released the first batch of assay results from its Phase 4 RC and diamond drilling program at the Island Gold Project (IGP), located between Mt Magnet and Cue in Western Australia’s Murchison Goldfields (Figure 1). Early results have delivered further high-grade intercepts at the Vadrians prospect, extending known gold mineralisation to ~300m vertical depth and demonstrating continuity of the system down plunge.

Mount Ridley Mines Limited (ASX: MRD) has announced a significant expansion of its tenure at the Mount Ridley Gallium and Rare Earth Project, located north of Esperance, Western Australia (Figure 1). The new Exploration Licences now consolidate the entire Grass Patch Complex — a distinctive geological domain marked by gravity and magnetic highs, interpreted to be associated with mafic intrusions, and recognised as a primary source of gallium and heavy rare earth enrichment.

West Cobar Metals Limited (ASX: WC1) has released new findings from the Salazar Critical Minerals Project, located approximately 150km northeast of Esperance (Figure 1). A detailed review and re-analysis of historical drilling, paired with new RC work across Newmont, O’Connor, and adjacent prospects, has confirmed extensive gallium mineralisation throughout the system.

OD6 Metals Limited (ASX: OD6) has announced the publication of a peer-reviewed scientific paper detailing three years of advanced geological and geochemical work at the Company’s flagship Splinter Rock Rare Earth Project in Western Australia (Figure 1). The research—undertaken by CSIRO, Murdoch University, Monash University, and OD6—provides a technical, science-backed understanding of how rare earth elements (REE) occur, concentrate, and can be extracted from this large clay

Proteomics International Laboratories Ltd (ASX: PIQ) has received $2.2 million in R&D tax incentive refunds for the 2024–25 financial year, reinforcing its financial position as the Company advances multiple diagnostic products towards commercialisation. Based in Perth, Western Australia, the Company continues to develop next-generation diagnostic tools built on its proprietary Promarker® technology platform, with applications across chronic disease detection, women’s health,